The Utah House and South Dakota House both overwhelmingly voted yesterday to pass 340B contract pharmacy access legislation, sending those [...] …
Category: Pharma Industry
A U.K.-based drug giant this week moved to add three specialty cancer treatment medications to its list of drugs subject [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
State lawmakers in Utah, New Mexico, Michigan, Kansas and Florida have all recently voted on or introduced bills to prohibit [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Chicago-based drugmaker recently added two new medications to its growing list of drugs subject to 340B contract pharmacy restrictions. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Several drugmakers recently notified covered entities of changes to their 340B drug ceiling prices, resulting in refunds, while others announced [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The drug industry’s legal fight against Missouri’s 340B contract pharmacy access law was dealt another blow yesterday after a federal [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Texas and Iowa have joined the growing list of states to introduce 340B contract pharmacy access bills in 2025, while [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The University of Kansas Hospital (UKHA) this week sued the federal government for authorizing Johnson & Johnson (J&J) to audit [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
News Alert
Dark-Money 340B Attacks, Rebate Model Among Key Concerns at 340B Coalition Winter Conference
Concerns over a highly charged and misleading dark-money campaign targeting state contract pharmacy access bills and the legal fight surrounding [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge yesterday rejected Swiss pharmaceutical company Novartis’ bid to block Missouri’s law prohibiting drugmaker 340B contract pharmacy restrictions [...] …